![tyme technologies tyme technologies](https://i1.wp.com/cnafinance.com/wp-content/uploads/2021/02/Tyme-Technologies-TYME-Stock-News.jpeg)
Open market or private sale of non-derivative or derivative securityĭisposition pursuant to a tender of shares in a change of control transactionĪcquisition or disposition by will or the laws of descent and distributionĮxercise of in-the-money or at-the-money derivative securityĭeposit into or withdrawal from voting trust Open market or private purchase of non-derivative or derivative security Stock analysis for Tyme Technologies Inc (TYME:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. Tyme is one of the world’s fastest-growing digital banking groups, building high-tech and high-touch banks in fast-growing, emerging markets. The business’s fifty day moving average price is 0.27 and its two-hundred day moving average price is 0.33. Consolidated Statements of Operations Years Ended Ma2020.
![tyme technologies tyme technologies](https://static.seekingalpha.com/uploads/sa_presentations/434/48434/slides/3.jpg)
SM 88, its proprietary drug candidate compound. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3Įxpiration (or cancellation) of long derivative position with value receivedĭiscretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securitiesĮxercise or conversion of derivative security exempted pursuant to Rule 16b-3Įxercise of out-of-the-money derivative security Shares of NASDAQ:TYME opened at 0.29 on Wednesday. Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. Grant, award or other acquisition pursuant to Rule 16b-3(d)ĭisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)